🌏 From Hong Kong: Rethinking Medical Inflation
Our Asia Launch Lead, Piet Maree, recently moderated a panel at the 7th Health Insurance & Healthcare Innovation Congress, exploring a question that continues to surface across markets:
Are we managing medical inflation… or managing around it?
Across the Asia-Pacific region, there is growing recognition that medical inflation is structural rather than cyclical. Costs are rising, utilisation is increasing, and pressure on affordability continues to build. Yet many responses remain reactive, focused on pricing rather than the underlying system.
What stood out in the discussion was a clear shift in thinking:
Sustainability is not just a cost problem. It is a system design problem.
When incentives across providers, payers, and patients are not aligned, systems tend to optimise for activity over outcomes, driving higher costs without improving value.
Encouragingly, there was strong alignment on the challenge, with the conversation moving beyond theory towards what actually works in practice. Many of the levers are already known. The real difficulty lies in aligning incentives and executing consistently across the ecosystem.
If current approaches persist, we are likely to see increased regulatory pressure and continued fragmentation in the near term.
Looking ahead, the question is no longer whether inflation can be managed, but whether the system can evolve.